story of the week
Long-Term Overall Survival Outcomes of Maintenance Olaparib in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial
J. Clin. Oncol 2022 Sep 09;[EPub Ahead of Print], P DiSilvestro, S Banerjee, N Colombo, G Scambia, BG Kim, A Oaknin, M Friedlander, A Lisyanskaya, A Floquet, A Leary, GS Sonke, C Gourley, A Oza, A González-Martín, C Aghajanian, W Bradley, C Mathews, J Liu, J McNamara, ES Lowe, ML Ah-See, KN MooreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.